Skip to main content

Nicotine Polacrilex

NDC 68071-3957 · NuCare Pharmaceuticals, Inc.

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

68071-3957-7 — 3 CONTAINER in 1 CARTON (68071-3957-7) / 72 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68016-280 — Nicotine Polacrilex, 68016-281 — Nicotine Polacrilex, 68016-284 — Nicotine Polacrilex, 68016-285 — Nicotine Polacrilex, 68016-286 — Nicotine Polacrilex, 68016-287 — Nicotine Polacrilex, 68016-292 — Nicotine Polacrilex, 68016-293 — Nicotine Polacrilex, 68016-559 — Nicotine Polacrilex, 68016-560 — Nicotine Polacrilex, 68196-012 — Nicotine polacrilex, 68196-029 — Nicotine Polacrilex, 68196-082 — Nicotine Polacrilex, 68196-084 — Nicotine Polacrilex, 68196-170 — Nicotine Polacrilex, 68196-194 — nicotine, 68196-269 — nicotine polacrilex, 68196-309 — Nicotine Polacrilex, 68196-734 — Nicotine Polacrilex, 68196-811 — nicotine polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels